HRT Financial’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

HRT Financial’s Portfolio BTAL Stock Details BTAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$154K	Sell	13,844 -138,962	-91%	-$1.69M	﹤0.01%	3481
2026 Q1	$2.13M	Sell	152,806 -29,445	-16%	-$413K	0.01%	1579
2025 Q4	$2.62M	Buy	+182,251	New	+$2.74M	0.01%	1128
2025 Q3	–	Sell	-13,816	Closed	-$244K	–	2898
2025 Q2	$244K	Buy	+13,816	New	+$269K	﹤0.01%	1971
2024 Q4	–	Sell	-27,044	Closed	-$530K	–	2477
2024 Q3	$530K	Buy	+27,044	New	+$538K	﹤0.01%	1560

Other funds holding BTAL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

CCA

Carrera Capital Advisors Troy, Michigan $675M AUM 17.92% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

HRT Financial's BTAL Position: Q2 2026 in Review

HRT Financial reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 91% in Q2 2026, selling an estimated $1.69M and leaving 13,844 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #3481.

HRT Financial first reported a position in BTAL in Q3 2024 and has held it in 5 quarters since. The position peaked at $2.62M in Q4 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

HRT Financial held 13,844 shares of AGF US Market Neutral Anti-Beta Fund worth $154K as of Q2 2026.
HRT Financial sold 138,962 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $1.69M.
AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3481 holding.
HRT Financial first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2024 and has held it in 5 quarters since.
HRT Financial's AGF US Market Neutral Anti-Beta Fund position peaked at $2.62M in Q4 2025.
93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.